GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Vita 34 AG (XTER:V3V) » Definitions » Price-to-Free-Cash-Flow

Vita 34 AG (XTER:V3V) Price-to-Free-Cash-Flow : N/A (As of May. 24, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Vita 34 AG Price-to-Free-Cash-Flow?

As of today (2024-05-24), Vita 34 AG's share price is €4.66. Vita 34 AG's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2023 was €-0.28. Hence, Vita 34 AG's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Vita 34 AG's Price-to-Free-Cash-Flow or its related term are showing as below:

During the past 13 years, Vita 34 AG's highest Price-to-Free-Cash-Flow Ratio was 220.31. The lowest was 6.00. And the median was 14.11.

XTER:V3V's Price-to-Free-Cash-Flow is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 17.11
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Vita 34 AG's Free Cash Flow per Share for the three months ended in Sep. 2023 was €0.05. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was €-0.28.

During the past 13 years, Vita 34 AG's highest 3-Year average Free Cash Flow per Share Growth Rate was 209.80% per year. The lowest was -55.80% per year. And the median was 23.75% per year.


Vita 34 AG Price-to-Free-Cash-Flow Historical Data

The historical data trend for Vita 34 AG's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vita 34 AG Price-to-Free-Cash-Flow Chart

Vita 34 AG Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.76 9.56 17.83 187.50 -

Vita 34 AG Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Vita 34 AG's Price-to-Free-Cash-Flow

For the Medical Care Facilities subindustry, Vita 34 AG's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vita 34 AG's Price-to-Free-Cash-Flow Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Vita 34 AG's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Vita 34 AG's Price-to-Free-Cash-Flow falls into.



Vita 34 AG Price-to-Free-Cash-Flow Calculation

Vita 34 AG's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=4.66/-0.279
=N/A

Vita 34 AG's Share Price of today is €4.66.
Vita 34 AG's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.28.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Vita 34 AG  (XTER:V3V) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Vita 34 AG Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Vita 34 AG's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Vita 34 AG (XTER:V3V) Business Description

Traded in Other Exchanges
Address
Deutscher Platz 5a, Leipzig, DEU, D-04103
Vita 34 AG is an umbilical cord blood bank. It supplies cryo-preservation and provides for the logistics to collect the blood, the preparation and the storage of stem cells from umbilical cord blood and tissue. The Group has two strategic areas that constitute the Group's reportable segments. Both segments are active in the field of stem cell banking, but differ in their organizational and operational structure with separate financial information. The products and services of the two segments correspond to the service portfolios of the two subgroups PBKM and Vita 34. It operates in Germany, Spain, and other international countries, of which maximum revenue is derived from the business operations in Germany.
Executives
Jakub Julian Baran Member of the Management Board
Dr. Alexander Granderath Supervisory Board

Vita 34 AG (XTER:V3V) Headlines

No Headlines